Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods to inhibit or enhance the binding of viral DNA to genomic host DNA

a technology of viral dna and genomic host, which is applied in the field of methods to inhibit or enhance the binding of viral dna to genomic host dna, can solve problems such as interfering with host processes, and achieve the effect of eliminating the persistence of disease-causing viruses and great avidity

Inactive Publication Date: 2003-07-17
RGT UNIV OF MICHIGAN
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0057] Sugden and colleagues hypothesized that EBNA 1 binds to specific DNA sequences on EBV and links this bound DNA through its many linking domains by interacting with chromosome associated proteins (Aiyar, A., et al. "The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element" EMBO 17:63940-6403, 1998). LANA may exhibit analogous functions to EBNA1 in linking KSHV episomes to host chromosomes thereby ensuring control of copy number, segregation, and persistence in the infected cell. LANA may also function as a viral defense against cellular pathways evolved to eliminate viral genetic material, similar to how EBNA 1 prevents over-whelming episomal loss in EBV infection (Aiyar, A., et al. "The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element" EMBO 17:63940-6403, 1998).
[0121] Adjuvants may be used to decrease the size of the DNA complex (e.g., 2-10 mM MgCl), to increase its stability (e.g., sucrose, dextrose, glycerol), or to improve delivery efficiency (e.g., lysosomotropic agents such as chloroquine and monensine). The complexes may be enclosed in a liposome to protect them and to facilitate their entry into the target cell (by fusion of the liposome with the cell membrane).

Problems solved by technology

For example, the modified oligonucleotide (or "lof"oligonucleotide") may, in effect, function as a diminisher of natural gene function if the natural gene is present and functional in the host into which the lof oligonucleotide was transfected, or may negatively interfere with processes in the host if the natural gene is not present or is non-functional.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods to inhibit or enhance the binding of viral DNA to genomic host DNA
  • Methods to inhibit or enhance the binding of viral DNA to genomic host DNA
  • Methods to inhibit or enhance the binding of viral DNA to genomic host DNA

Examples

Experimental program
Comparison scheme
Effect test

experiment 1

[0134] Experiment 1

[0135] LANA and KSHV episomes localize similarly to host chromatin in KSHV infected cells. To determine if KSHV achieves latency by integrating to host DNA, we conducted fluorescent in-situ hybridization (FISH) studies with several viral cosmid probes on metaphase chromosomes prepared from a KSHV positive / EBV negative cell line (BC-3) derived from a body cavity lymphoma as well as a KSHV negative B cell line (BJAB). While viral DNA was not detected in the symmetrical pattern achieved by replication of a chromatid to which virus has integrated, it was consistently detected in a seemingly random association with host chromosomes (FIG. 1a). Furthermore, when similar chromosome spreads derived from the same KSHV positive cells were probed with a human serum that specifically recognizes LANA (FIG. 1b), we demonstrated that LANA localized to the host chromosomes in a pattern strikingly similar to that of KSHV specific DNA hybridization in FIG. 1a. FIG. 1c shows a non-sp...

experiment 2

[0136] LANA displays preferential binding to different regions of KSHV DNA in vitro. To ascertain if LANA had the capacity to bind specific sequences in KSHV DNA, .sup.32P-dCTP radiolabeled probes spanning the viral genome (FIG. 2b) were incubated with in vitro translated .sup.35S-methionine labeled LANA-myc fusion protein, followed by immunoprecipitation with anti-myc antibodies. To detect probes specifically bound to LANA, immunoprecipitates were quantified by liquid scintillation counting. Binding of LANA to DNA was expressed as a percentage of total probe that coimmunoprecipitated with LANA-myc. The results of this experiment, shown in FIG. 2a, demonstrated that LANA most preferentially bound a region of the KSHV genome referred to as Z2, located at approximately 127-140 kb on the right end of the viral genome (Russo, J. "Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)" PNAS 93:14862-14867, 1996). FIG. 2a is a representative of three separate experiments ...

experiment 3

[0137] LANA and KSHV DNA colocalize to metaphase chromosomes in KSHV infected cells. To determine if LANA colocalized with KSHV DNA, chromosome spreads were generated from cells prepared by fixing for only one hour in an effort to retain chromosome-associated antigens that would be lost by the typical overnight fixation used in standard FISH protocols as shown in FIG. 1a. These spreads were probed with KSHV DNA and amplified via a tyramide based fluorochrome deposition (NEN-Lifesciences) for increased sensitivity, followed immediately by anti-LANA immunofluorescence in an effort to colocalize viral DNA and LANA protein at host chromosomes. When both signals from the KSHV probe and the anti-LANA antibody were superimposed it became evident that both signals were colocalized to the chromosomes in BC-3 (FIG. 3d) but not BJAB cells (FIG. 3h).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
fixation timeaaaaaaaaaa
Login to View More

Abstract

This invention relates to novel reagents and methods for the screening of compounds that may be agonistic or antagonistic to the binding of viral DNA to the chromosomes of host cells, that may be used in gene therapy and that may be used to treat tumor viruses.

Description

[0002] This invention generally relates to novel compounds and methods for the detection of compounds that are agonistic or antagonistic for the binding of viral genetic material to genomic host DNA. Additionally, the inventions generally relates to compounds and methods related to gene transfer and gene therapy, as well as therapeutics for virally based diseases.[0003] In 1872, Moritz Kaposi described a multifocal vascular tumor affecting elderly men of Mediterranean or Eastern European origin. More recently, this neoplasm has become prevalent in immunocompromised patients, such as transplant recipients on immunosuppressive therapy, and AIDS patients, where it has become the most common cancer (Beral, V. "Epidemiology of Kaposi's sarcoma" Cancer Surv 10:5-22, 1991). The relationship of the disease to geography and immunocompromised patients led to the suspicion of an infectious agent in Kaposi's sarcoma pathogenesis. This suspicion was supported when KSHV or human herpesvirus 8 (HH...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K14/03C12N7/01C12Q1/70G01N33/569
CPCC07K14/005G01N33/56983C12Q1/70C12N2710/16222
Inventor ROBERTSON, ERLE S.COTTER, MURRAY A.
Owner RGT UNIV OF MICHIGAN